BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis--tracing the accessory. Oncogene. 2014;33:3217-3224. [PMID: 23851506 DOI: 10.1038/onc.2013.272] [Cited by in Crossref: 129] [Cited by in F6Publishing: 131] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Yue W, Wang T, Zachariah E, Lin Y, Yang CS, Xu Q, DiPaola RS, Tan XL. Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy. Sci Rep 2015;5:13390. [PMID: 26294325 DOI: 10.1038/srep13390] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
2 Fujishita T, Kajino-Sakamoto R, Kojima Y, Taketo MM, Aoki M. Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in Apc(Δ716) mice involves stromal COX-2. Cancer Sci 2015;106:692-9. [PMID: 25855137 DOI: 10.1111/cas.12670] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhou JX, Taramelli R, Pedrini E, Knijnenburg T, Huang S. Extracting Intercellular Signaling Network of Cancer Tissues using Ligand-Receptor Expression Patterns from Whole-tumor and Single-cell Transcriptomes. Sci Rep 2017;7:8815. [PMID: 28821810 DOI: 10.1038/s41598-017-09307-w] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
4 Rezaeeyan H, Shirzad R, McKee TD, Saki N. Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach. APMIS 2018;126:359-70. [PMID: 29676815 DOI: 10.1111/apm.12818] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
5 Campbell JM, Balhoff JB, Landwehr GM, Rahman SM, Vaithiyanathan M, Melvin AT. Microfluidic and Paper-Based Devices for Disease Detection and Diagnostic Research. Int J Mol Sci 2018;19:E2731. [PMID: 30213089 DOI: 10.3390/ijms19092731] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
6 Hosseini F, Hassannia H, Mahdian-Shakib A, Jadidi-Niaragh F, Enderami SE, Fattahi M, Anissian A, Mirshafiey A, Kokhaei P. Targeting of crosstalk between tumor and tumor microenvironment by β-D mannuronic acid (M2000) in murine breast cancer model. Cancer Med 2017;6:640-50. [PMID: 28211615 DOI: 10.1002/cam4.1013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
7 Coniglio SJ. Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis. Front Endocrinol (Lausanne) 2018;9:313. [PMID: 29930538 DOI: 10.3389/fendo.2018.00313] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
8 Rahman SM, Campbell JM, Coates RN, Render KM, Byrne CE, Martin EC, Melvin AT. Evaluation of intercellular communication between breast cancer cells and adipose-derived stem cells via passive diffusion in a two-layer microfluidic device. Lab Chip 2020;20:2009-19. [PMID: 32379852 DOI: 10.1039/d0lc00142b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
9 An YZ, Cho E, Ling J, Zhang X. The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma. BMC Cancer 2020;20:987. [PMID: 33046030 DOI: 10.1186/s12885-020-07495-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Dietrich K, Fiedler IA, Kurzyukova A, López-Delgado AC, McGowan LM, Geurtzen K, Hammond CL, Busse B, Knopf F. Skeletal Biology and Disease Modeling in Zebrafish. J Bone Miner Res 2021;36:436-58. [PMID: 33484578 DOI: 10.1002/jbmr.4256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Samaržija I. Site-Specific and Common Prostate Cancer Metastasis Genes as Suggested by Meta-Analysis of Gene Expression Data. Life (Basel) 2021;11:636. [PMID: 34209195 DOI: 10.3390/life11070636] [Reference Citation Analysis]
12 Bauer TV, Tregubchak TV, Maksyutov AZ, Kolosova IV, Maksyutov RA, Gavrilova EV. [Development of the drug oncolytic immunotherapy based on vaccinia viruses (Vaccinia virus, Orthopoxvirus, Chordopoxvirinae, Poxviridae) against breast cancer.]. Vopr Virusol 2020;65:49-56. [PMID: 32496721 DOI: 10.36233/0507-4088-2020-65-1-49-56] [Reference Citation Analysis]
13 Wang N, Meng X, Liu Y, Chen Y, Liang Q. LPS promote Osteosarcoma invasion and migration through TLR4/HOTAIR. Gene 2019;680:1-8. [PMID: 30240881 DOI: 10.1016/j.gene.2018.09.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
14 Roblek M, Calin M, Schlesinger M, Stan D, Zeisig R, Simionescu M, Bendas G, Borsig L. Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis. J Control Release 2015;220:341-7. [PMID: 26522070 DOI: 10.1016/j.jconrel.2015.10.055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
15 Wang Y, Ren S, Wang Z, Wang Z, Zhu N, Cai D, Ye Z, Ruan J. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities. Int Immunopharmacol 2020;87:106815. [PMID: 32711376 DOI: 10.1016/j.intimp.2020.106815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Wang LH, Lin CY, Liu SC, Liu GT, Chen YL, Chen JJ, Chan CH, Lin TY, Chen CK, Xu GH, Chen SS, Tang CH, Wang SW. CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells. Oncotarget 2016;7:36896-908. [PMID: 27166194 DOI: 10.18632/oncotarget.9213] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
17 Gorgel SN, Akin Y, Koc EM, Kose O, Ozcan S, Yilmaz Y. Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre. Int Urol Nephrol 2020;52:469-73. [PMID: 31659597 DOI: 10.1007/s11255-019-02325-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 da Silva PHR, Borges BC, Uehara IA, Soldi LR, de Araújo RA, Silva MJB. Chemokines and the extracellular matrix: Set of targets for tumor development and treatment. Cytokine 2021;144:155548. [PMID: 33972165 DOI: 10.1016/j.cyto.2021.155548] [Reference Citation Analysis]
19 Chéné AL, d'Almeida S, Blondy T, Tabiasco J, Deshayes S, Fonteneau JF, Cellerin L, Delneste Y, Grégoire M, Blanquart C. Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages. J Thorac Oncol 2016;11:1765-73. [PMID: 27418105 DOI: 10.1016/j.jtho.2016.06.022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
20 Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, Azmi AS, Lokeshwar BL, Grue B, Panis C, Boosani CS, Poudyal D, Stafforini DM, Bhakta D, Niccolai E, Guha G, Vasantha Rupasinghe HP, Fujii H, Honoki K, Mehta K, Aquilano K, Lowe L, Hofseth LJ, Ricciardiello L, Ciriolo MR, Singh N, Whelan RL, Chaturvedi R, Ashraf SS, Shantha Kumara HMC, Nowsheen S, Mohammed SI, Keith WN, Helferich WG, Yang X. A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol 2015;35 Suppl:S151-84. [PMID: 25951989 DOI: 10.1016/j.semcancer.2015.03.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 8.4] [Reference Citation Analysis]
21 Tang J, Chen Y, Cui R, Li D, Xiao L, Lin P, Du Y, Sun H, Yu X, Zheng X. Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition. Mol Med Rep 2015;12:7907-14. [PMID: 26496926 DOI: 10.3892/mmr.2015.4438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
22 Shimizu N, Hamaide A, Dourcy M, Noël S, Clercx C, Teske E. Evaluation of urinary and serum level of chemokine (C-C motif) ligand 2 as a potential biomarker in canine urothelial tumours. Vet Comp Oncol 2019;17:11-20. [PMID: 30588734 DOI: 10.1111/vco.12436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
23 Castel H, Desrues L, Joubert JE, Tonon MC, Prézeau L, Chabbert M, Morin F, Gandolfo P. The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.Front Endocrinol (Lausanne). 2017;8:76. [PMID: 28487672 DOI: 10.3389/fendo.2017.00076] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
24 Wang SW, Liu SC, Sun HL, Huang TY, Chan CH, Yang CY, Yeh HI, Huang YL, Chou WY, Lin YM, Tang CH. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment. Carcinogenesis. 2015;36:104-114. [PMID: 25330803 DOI: 10.1093/carcin/bgu218] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 9.1] [Reference Citation Analysis]
25 Lebel-Haziv Y, Meshel T, Soria G, Yeheskel A, Mamon E, Ben-Baruch A. Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs. Neoplasia 2014;16:723-40. [PMID: 25246273 DOI: 10.1016/j.neo.2014.08.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
26 Jiang X, Wang J, Chen X, Hong Y, Wu T, Chen X, Xia J, Cheng B. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation. Oncotarget 2016;7:16262-72. [PMID: 26919103 DOI: 10.18632/oncotarget.7585] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
27 Chen L, Zuo Y, Zhu L, Zhang Y, Li S, Ma F, Han Y, Song H, Xue Y. Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy. Onco Targets Ther 2017;10:2569-80. [PMID: 28553122 DOI: 10.2147/OTT.S134716] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
28 Zhu Y, Wen L, Shao S, Tan Y, Meng T, Yang X, Liu Y, Liu X, Yuan H, Hu F. Inhibition of tumor-promoting stroma to enforce subsequently targeting AT1R on tumor cells by pathological inspired micelles. Biomaterials 2018;161:33-46. [PMID: 29421561 DOI: 10.1016/j.biomaterials.2018.01.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
29 Chouaib S, Umansky V, Kieda C. The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment. Contemp Oncol (Pozn) 2018;22:7-13. [PMID: 29628788 DOI: 10.5114/wo.2018.73874] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
30 Volodko N, Gutor T, Petronchak O, Huley R, Dúcka M, Šmarda J, Borsig L, Beneš P, Knopfová L. Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors. Sci Rep 2019;9:11634. [PMID: 31406165 DOI: 10.1038/s41598-019-48051-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Katsura A, Suzuki HI, Ueno T, Mihira H, Yamazaki T, Yasuda T, Watabe T, Mano H, Yamada Y, Miyazono K. MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β. Genes Cells 2016;21:99-116. [PMID: 26663584 DOI: 10.1111/gtc.12323] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
32 Saxena S, Singh RK. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. Cancer Metastasis Rev 2021;40:447-76. [PMID: 33959849 DOI: 10.1007/s10555-021-09970-6] [Reference Citation Analysis]
33 Brummer G, Fang W, Smart C, Zinda B, Alissa N, Berkland C, Miller D, Cheng N. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. Oncogene 2020;39:2275-89. [PMID: 31827233 DOI: 10.1038/s41388-019-1141-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
34 Kim MJ, Kim KM, Kim J, Kim KN. BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release. PLoS One 2014;9:e108170. [PMID: 25271422 DOI: 10.1371/journal.pone.0108170] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
35 Chen S, Yang L, Dong H, Guo H. Human telomerase reverse transcriptase recruits the β-catenin/TCF-4 complex to transactivate chemokine (C-C motif) ligand 2 expression in colorectal cancer. Biomed Pharmacother 2019;112:108700. [PMID: 30970512 DOI: 10.1016/j.biopha.2019.108700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Vlasova-St Louis I, Bohjanen PR. Post-transcriptional regulation of cytokine and growth factor signaling in cancer. Cytokine Growth Factor Rev 2017;33:83-93. [PMID: 27956133 DOI: 10.1016/j.cytogfr.2016.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
37 Knopfová L, Biglieri E, Volodko N, Masařík M, Hermanová M, Glaus Garzón JF, Dúcka M, Kučírková T, Souček K, Šmarda J, Beneš P, Borsig L. Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding. Oncogene 2018;37:1020-30. [PMID: 29084208 DOI: 10.1038/onc.2017.392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
38 Peña CG, Nakada Y, Saatcioglu HD, Aloisio GM, Cuevas I, Zhang S, Miller DS, Lea JS, Wong KK, DeBerardinis RJ, Amelio AL, Brekken RA, Castrillon DH. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. J Clin Invest 2015;125:4063-76. [PMID: 26413869 DOI: 10.1172/JCI82152] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
39 Janmaat VT, Liu H, da Silva RA, Wisse PHA, Spaander MCW, Ten Hagen TLM, Smits R, Bruno MJ, Fuhler GM, Peppelenbosch MP. HOXA9 mediates and marks premalignant compartment size expansion in colonic adenomas. Carcinogenesis 2019;40:1514-24. [PMID: 31099823 DOI: 10.1093/carcin/bgz038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Lee JM, Lee HS, Hyun JJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Chun HJ, Um SH, Kim CD. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. World J Gastrointest Oncol 2016; 8(7): 555-562 [PMID: 27559435 DOI: 10.4251/wjgo.v8.i7.555] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
41 Niess H, Thomas MN, Schiergens TS, Kleespies A, Jauch KW, Bruns C, Werner J, Nelson PJ, Angele MK. Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horses. Innov Surg Sci 2016;1:19-32. [PMID: 31579715 DOI: 10.1515/iss-2016-0005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
42 Cristofoletti C, Bresin A, Picozza M, Picchio MC, Monzo F, Helmer Citterich M, Passarelli F, Frezzolini A, Scala E, Monopoli A, Cantonetti M, Benucci R, D'Atri S, Caprini E, Russo G, Narducci MG. Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance. Leukemia 2019;33:1231-42. [PMID: 30518812 DOI: 10.1038/s41375-018-0305-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
43 Weng CC, Hsieh MJ, Wu CC, Lin YC, Shan YS, Hung WC, Chen LT, Cheng KH. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer. Mol Cancer 2019;18:96. [PMID: 31109321 DOI: 10.1186/s12943-019-1023-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
44 Lerrer S, Liubomirski Y, Bott A, Abnaof K, Oren N, Yousaf A, Körner C, Meshel T, Wiemann S, Ben-Baruch A. Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells. Front Immunol 2017;8:479. [PMID: 28553282 DOI: 10.3389/fimmu.2017.00479] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
45 Morein D, Rubinstein-Achiasaf L, Brayer H, Dorot O, Pichinuk E, Ben-Yaakov H, Meshel T, Pasmanik-Chor M, Ben-Baruch A. Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells. Cells 2021;10:1356. [PMID: 34072893 DOI: 10.3390/cells10061356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Liubomirski Y, Lerrer S, Meshel T, Rubinstein-Achiasaf L, Morein D, Wiemann S, Körner C, Ben-Baruch A. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Front Immunol 2019;10:757. [PMID: 31031757 DOI: 10.3389/fimmu.2019.00757] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 14.7] [Reference Citation Analysis]
47 Ishida Y, Kuninaka Y, Yamamoto Y, Nosaka M, Kimura A, Furukawa F, Mukaida N, Kondo T. Pivotal Involvement of the CX3CL1-CX3CR1 Axis for the Recruitment of M2 Tumor-Associated Macrophages in Skin Carcinogenesis. J Invest Dermatol 2020;140:1951-1961.e6. [PMID: 32179066 DOI: 10.1016/j.jid.2020.02.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
48 Garcia-Monclús S, López-Alemany R, Almacellas-Rabaiget O, Herrero-Martín D, Huertas-Martinez J, Lagares-Tena L, Alba-Pavón P, Hontecillas-Prieto L, Mora J, de Álava E, Rello-Varona S, Giangrande PH, Tirado OM. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma. Int J Cancer 2018;143:1188-201. [PMID: 29582409 DOI: 10.1002/ijc.31405] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
49 Liu J, Li Y, Zhu X, Li Q, Liang X, Xie J, Hu S, Peng W, Li C. Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma. Oncol Lett 2019;17:4877-90. [PMID: 31186696 DOI: 10.3892/ol.2019.10211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
50 Bendas G, Borsig L. Heparanase in Cancer Metastasis – Heparin as a Potential Inhibitor of Cell Adhesion Molecules. In: Vlodavsky I, Sanderson RD, Ilan N, editors. Heparanase. Cham: Springer International Publishing; 2020. pp. 309-29. [DOI: 10.1007/978-3-030-34521-1_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Jeon JS, Bersini S, Gilardi M, Dubini G, Charest JL, Moretti M, Kamm RD. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci U S A 2015;112:214-9. [PMID: 25524628 DOI: 10.1073/pnas.1417115112] [Cited by in Crossref: 399] [Cited by in F6Publishing: 358] [Article Influence: 49.9] [Reference Citation Analysis]
52 Jeong W, Kim HJ. Biomarkers of chondrosarcoma. J Clin Pathol 2018;71:579-83. [PMID: 29593061 DOI: 10.1136/jclinpath-2018-205071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
53 Pedrazzani C, Mantovani G, Fernandes E, Bagante F, Luca Salvagno G, Surci N, Campagnaro T, Ruzzenente A, Danese E, Lippi G, Guglielmi A. Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer. Sci Rep 2017;7:1494. [PMID: 28473700 DOI: 10.1038/s41598-017-01652-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 8.4] [Reference Citation Analysis]
54 Gong Z, Ma J, Su H, Guo T, Cai H, Chen Q, Zhao X, Qi J, Du J. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer. Int J Clin Oncol 2018;23:659-70. [PMID: 29344744 DOI: 10.1007/s10147-018-1242-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
55 Choi M, Jo H, Kim D, Yun J, Kang JS, Kim Y, Jung JK, Hong JT, Cho J, Kwak JH, Lee H. Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents. Arch Pharm Res 2016;39:618-30. [PMID: 27021311 DOI: 10.1007/s12272-016-0737-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Vergani E, Di Guardo L, Dugo M, Rigoletto S, Tragni G, Ruggeri R, Perrone F, Tamborini E, Gloghini A, Arienti F, Vergani B, Deho P, De Cecco L, Vallacchi V, Frati P, Shahaj E, Villa A, Santinami M, De Braud F, Rivoltini L, Rodolfo M. Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b. Oncotarget 2016;7:4428-41. [PMID: 26684239 DOI: 10.18632/oncotarget.6599] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 8.8] [Reference Citation Analysis]
57 Schröder S, Broese S, Baake J, Juerß D, Kriesen S, Hildebrandt G, Manda K. Effect of Ionizing Radiation on Human EA.hy926 Endothelial Cells under Inflammatory Conditions and Their Interactions with A549 Tumour Cells. J Immunol Res 2019;2019:9645481. [PMID: 31565662 DOI: 10.1155/2019/9645481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
58 Hawila E, Razon H, Wildbaum G, Blattner C, Sapir Y, Shaked Y, Umansky V, Karin N. CCR5 Directs the Mobilization of CD11b+Gr1+Ly6Clow Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Development. Cell Reports 2017;21:2212-22. [DOI: 10.1016/j.celrep.2017.10.104] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
59 Brummer G, Acevedo DS, Hu Q, Portsche M, Fang WB, Yao M, Zinda B, Myers M, Alvarez N, Fields P, Hong Y, Behbod F, Cheng N. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms. Mol Cancer Res 2018;16:296-308. [PMID: 29133591 DOI: 10.1158/1541-7786.MCR-17-0308] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
60 Hirshberg A, Berger R, Allon I, Kaplan I. Metastatic tumors to the jaws and mouth. Head Neck Pathol 2014;8:463-74. [PMID: 25409855 DOI: 10.1007/s12105-014-0591-z] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 8.4] [Reference Citation Analysis]
61 Ge WL, Chen Q, Meng LD, Huang XM, Shi GD, Zong QQ, Shen P, Lu YC, Zhang YH, Miao Y, Zhang JJ, Jiang KR. The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Cell Death Dis 2020;11:294. [PMID: 32341359 DOI: 10.1038/s41419-020-2475-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Pervaiz A, Zepp M, Georges R, Bergmann F, Mahmood S, Faiza S, Berger MR, Adwan H. Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis. J Cancer Res Clin Oncol 2021;147:73-91. [PMID: 32902795 DOI: 10.1007/s00432-020-03382-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Liubomirski Y, Lerrer S, Meshel T, Morein D, Rubinstein-Achiasaf L, Sprinzak D, Wiemann S, Körner C, Ehrlich M, Ben-Baruch A. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Front Immunol 2019;10:804. [PMID: 31105691 DOI: 10.3389/fimmu.2019.00804] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
64 Park J, Zhang X, Lee SK, Song NY, Son SH, Kim KR, Shim JH, Park KK, Chung WY. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion. J Clin Invest 2019;129:5381-99. [PMID: 31487270 DOI: 10.1172/JCI125336] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
65 Chen L, Yan Y, Zhu L, Cong X, Li S, Song S, Song H, Xue Y. Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy. Cancer Manag Res 2017;9:849-67. [PMID: 29276407 DOI: 10.2147/CMAR.S151026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
66 Datar I, Qiu X, Ma HZ, Yeung M, Aras S, de la Serna I, Al-Mulla F, Thiery JP, Trumbly R, Fan X, Cui H, Yeung KC. RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration. Oncotarget 2015;6:39050-61. [PMID: 26375811 DOI: 10.18632/oncotarget.5176] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
67 Ming H, Li B, Zhou L, Goel A, Huang C. Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications. Biochim Biophys Acta Rev Cancer 2021;1875:188519. [PMID: 33548345 DOI: 10.1016/j.bbcan.2021.188519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
68 Lubowicka E, Przylipiak A, Zajkowska M, Piskór BM, Malinowski P, Fiedorowicz W, Ławicki S. Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients. Biomed Res Int 2018;2018:2124390. [PMID: 30151375 DOI: 10.1155/2018/2124390] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
69 Zhou H, Lei PJ, Padera TP. Progression of Metastasis through Lymphatic System. Cells 2021;10:627. [PMID: 33808959 DOI: 10.3390/cells10030627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Wu W, Ren F, Guo M, Yang J, Xiao Y, Liu W. Increased expression of CX3CL1 and CX3CR1 in papillary thyroid carcinoma. Histol Histopathol 2020;35:1189-96. [PMID: 32975307 DOI: 10.14670/HH-18-265] [Reference Citation Analysis]
71 Hagenhoff A, Bruns CJ, Zhao Y, von Lüttichau I, Niess H, Spitzweg C, Nelson PJ. Harnessing mesenchymal stem cell homing as an anticancer therapy. Expert Opin Biol Ther 2016;16:1079-92. [PMID: 27270211 DOI: 10.1080/14712598.2016.1196179] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
72 Chen L, Kong X, Yan C, Fang Y, Wang J. The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer. Onco Targets Ther 2020;13:1397-412. [PMID: 32104003 DOI: 10.2147/OTT.S227171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
73 Peng Q, Zhang J, Ye X, Zhou G. Tumor-like microenvironment in oral lichen planus: evidence of malignant transformation? Expert Review of Clinical Immunology 2017;13:635-43. [DOI: 10.1080/1744666x.2017.1295852] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
74 Sprangers B, Nair V, Launay-Vacher V, Riella LV, Jhaveri KD. Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network. Clin Kidney J. 2018;11:315-329. [PMID: 29942495 DOI: 10.1093/ckj/sfx122] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
75 Gschwandtner M, Derler R, Midwood KS. More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis. Front Immunol 2019;10:2759. [PMID: 31921102 DOI: 10.3389/fimmu.2019.02759] [Cited by in Crossref: 94] [Cited by in F6Publishing: 91] [Article Influence: 31.3] [Reference Citation Analysis]
76 Aarstad HJ, Aarstad HH, Vintermyr OK, Kross KW, Lybak S, Heimdal JH. In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients. Scand J Immunol 2017;85:211-9. [PMID: 27943380 DOI: 10.1111/sji.12518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
77 Agalioti T, Giannou AD, Krontira AC, Kanellakis NI, Kati D, Vreka M, Pepe M, Spella M, Lilis I, Zazara DE, Nikolouli E, Spiropoulou N, Papadakis A, Papadia K, Voulgaridis A, Harokopos V, Stamou P, Meiners S, Eickelberg O, Snyder LA, Antimisiaris SG, Kardamakis D, Psallidas I, Marazioti A, Stathopoulos GT. Mutant KRAS promotes malignant pleural effusion formation. Nat Commun 2017;8:15205. [PMID: 28508873 DOI: 10.1038/ncomms15205] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
78 Liu Q, Zhang H, Jiang X, Qian C, Liu Z, Luo D. Factors involved in cancer metastasis: a better understanding to "seed and soil" hypothesis. Mol Cancer 2017;16:176. [PMID: 29197379 DOI: 10.1186/s12943-017-0742-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 14.0] [Reference Citation Analysis]
79 Kalvakolanu DV. The “Yin-Yang” of cytokines in cancer. Cytokine 2019;118:1-2. [DOI: 10.1016/j.cyto.2018.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Reyes N, Figueroa S, Tiwari R, Geliebter J. CXCL3 Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2021;1302:15-24. [PMID: 34286438 DOI: 10.1007/978-3-030-62658-7_2] [Reference Citation Analysis]
81 Ahmat Amin MKB, Shimizu A, Zankov DP, Sato A, Kurita S, Ito M, Maeda T, Yoshida T, Sakaue T, Higashiyama S, Kawauchi A, Ogita H. Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1. Oncogene 2018;37:5416-34. [PMID: 29867202 DOI: 10.1038/s41388-018-0286-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
82 Katanov C, Lerrer S, Liubomirski Y, Leider-Trejo L, Meshel T, Bar J, Feniger-Barish R, Kamer I, Soria-Artzi G, Kahani H. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Stem Cell Res Ther. 2015;6:87. [PMID: 25928089 DOI: 10.1186/s13287-015-0080-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 9.1] [Reference Citation Analysis]
83 Bernard S, Myers M, Fang WB, Zinda B, Smart C, Lambert D, Zou A, Fan F, Cheng N. CXCL1 Derived from Mammary Fibroblasts Promotes Progression of Mammary Lesions to Invasive Carcinoma through CXCR2 Dependent Mechanisms. J Mammary Gland Biol Neoplasia 2018;23:249-67. [PMID: 30094610 DOI: 10.1007/s10911-018-9407-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
84 Häuselmann I, Roblek M, Protsyuk D, Huck V, Knopfova L, Grässle S, Bauer AT, Schneider SW, Borsig L. Monocyte Induction of E-Selectin-Mediated Endothelial Activation Releases VE-Cadherin Junctions to Promote Tumor Cell Extravasation in the Metastasis Cascade. Cancer Res 2016;76:5302-12. [PMID: 27488527 DOI: 10.1158/0008-5472.CAN-16-0784] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
85 Kalvakolanu DV. Twenty five years of Cytokine: on a forward path to exciting discoveries of pathological mechanisms and therapeutics. Cytokine 2017;98:1-3. [PMID: 28863832 DOI: 10.1016/j.cyto.2017.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
86 Vela M, Aris M, Llorente M, Garcia-Sanz JA, Kremer L. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges. Front Immunol 2015;6:12. [PMID: 25688243 DOI: 10.3389/fimmu.2015.00012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 8.4] [Reference Citation Analysis]
87 Baram T, Rubinstein-Achiasaf L, Ben-Yaakov H, Ben-Baruch A. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy. Front Oncol 2020;10:614468. [PMID: 33585241 DOI: 10.3389/fonc.2020.614468] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
88 Chen Q, Wu H, Guo X, Gu K, Wang W, Chen X, Ji S, Yang H, Zhu J. The Change of Systemic Immune-Inflammation Index Independently Predicts Survival of Colorectal Cancer Patients after Curative Resection. Mediators Inflamm 2020;2020:4105809. [PMID: 33293896 DOI: 10.1155/2020/4105809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Kim J, Xu Z, Marignani PA. Single-cell RNA sequencing for the identification of early-stage lung cancer biomarkers from circulating blood. NPJ Genom Med 2021;6:87. [PMID: 34654834 DOI: 10.1038/s41525-021-00248-y] [Reference Citation Analysis]
90 Nojiri T, Hosoda H, Tokudome T, Miura K, Ishikane S, Otani K, Kishimoto I, Shintani Y, Inoue M, Kimura T, Sawabata N, Minami M, Nakagiri T, Funaki S, Takeuchi Y, Maeda H, Kidoya H, Kiyonari H, Shioi G, Arai Y, Hasegawa T, Takakura N, Hori M, Ohno Y, Miyazato M, Mochizuki N, Okumura M, Kangawa K. Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells. Proc Natl Acad Sci U S A 2015;112:4086-91. [PMID: 25775533 DOI: 10.1073/pnas.1417273112] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
91 Aravalli RN, Greten TF. FoxC1: Novel Regulator of Inflammation-Induced Metastasis in Hepatocellular Carcinoma. Gastroenterology 2015;149:861-3. [PMID: 26302490 DOI: 10.1053/j.gastro.2015.08.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
92 Itoh H, Kadomatsu T, Tanoue H, Yugami M, Miyata K, Endo M, Morinaga J, Kobayashi E, Miyamoto T, Kurahashi R, Terada K, Mizuta H, Oike Y. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma. Oncogene 2018;37:2903-20. [DOI: 10.1038/s41388-018-0160-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
93 Reddy UG, Danovitch GM. Transplantation. T-cell depletion--balancing acute rejection and cancer risk. Nat Rev Nephrol 2014;10:301-2. [PMID: 24709843 DOI: 10.1038/nrneph.2014.61] [Reference Citation Analysis]
94 Sun J, Wang X, Zhang Z, Zeng Z, Ouyang S, Kang W. The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer. Front Oncol 2021;11:641304. [PMID: 33937042 DOI: 10.3389/fonc.2021.641304] [Reference Citation Analysis]
95 Lim JB, Chung HW. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Cytokine. 2015;73:16-22. [PMID: 25689618 DOI: 10.1016/j.cyto.2015.01.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
96 Elgström E, Ohlsson TG, Eriksson SE. Cytokine evaluation in untreated and radioimmunotherapy-treated tumors in an immunocompetent rat model. Tumour Biol 2017;39:1010428317697550. [PMID: 28381167 DOI: 10.1177/1010428317697550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
97 Novak M, Koprivnikar Krajnc M, Hrastar B, Breznik B, Majc B, Mlinar M, Rotter A, Porčnik A, Mlakar J, Stare K, Pestell RG, Lah Turnšek T. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment. Int J Mol Sci 2020;21:E4199. [PMID: 32545571 DOI: 10.3390/ijms21124199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
98 Ku WT, Tung JJ, Lee TJ, Lai KC. Long-Term Exposure to Oroxylin A Inhibits Metastasis by Suppressing CCL2 in Oral Squamous Cell Carcinoma Cells. Cancers (Basel) 2019;11:E353. [PMID: 30871117 DOI: 10.3390/cancers11030353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
99 Roblek M, Protsyuk D, Becker PF, Stefanescu C, Gorzelanny C, Glaus Garzon JF, Knopfova L, Heikenwalder M, Luckow B, Schneider SW, Borsig L. CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis. Mol Cancer Res 2019;17:783-93. [PMID: 30552233 DOI: 10.1158/1541-7786.MCR-18-0530] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
100 Xia L, Zhu X, Zhang L, Xu Y, Chen G, Luo J. EZH2 enhances expression of CCL5 to promote recruitment of macrophages and invasion in lung cancer. Biotechnol Appl Biochem 2020;67:1011-9. [PMID: 31855281 DOI: 10.1002/bab.1875] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
101 Ding Q, Xia Y, Ding S, Lu P, Sun L, Liu M. An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9. Oncotarget 2016;7:14405-14. [PMID: 26883105 DOI: 10.18632/oncotarget.7360] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
102 Kim DH, Lee HS, Mun Y, Koh S, Park J, Lee SM, Kang N, Lee MY, Cho C, Kim D, Lee J. An overview of chondrosarcoma with a focus on nanoscale therapeutics. J Pharm Investig 2020;50:537-52. [DOI: 10.1007/s40005-020-00492-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Marcuzzi E, Angioni R, Molon B, Calì B. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization. Int J Mol Sci 2018;20:E96. [PMID: 30591657 DOI: 10.3390/ijms20010096] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
104 Le Joncour V, Guichet PO, Dembélé KP, Mutel A, Campisi D, Perzo N, Desrues L, Modzelewski R, Couraud PO, Honnorat J, Ferracci FX, Marguet F, Laquerrière A, Vera P, Bohn P, Langlois O, Morin F, Gandolfo P, Castel H. Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma. Front Cell Dev Biol 2021;9:652544. [PMID: 33937253 DOI: 10.3389/fcell.2021.652544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Arabzadeh A, Dupaul-Chicoine J, Breton V, Haftchenary S, Yumeen S, Turbide C, Saleh M, McGregor K, Greenwood CM, Akavia UD, Blumberg RS, Gunning PT, Beauchemin N. Carcinoembryonic Antigen Cell Adhesion Molecule 1 long isoform modulates malignancy of poorly differentiated colon cancer cells. Gut 2016;65:821-9. [PMID: 25666195 DOI: 10.1136/gutjnl-2014-308781] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
106 Xiang Z, Zhou ZJ, Xia GK, Zhang XH, Wei ZW, Zhu JT, Yu J, Chen W, He Y, Schwarz RE, Brekken RA, Awasthi N, Zhang CH. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis. Oncogene 2017;36:5122-33. [PMID: 28481874 DOI: 10.1038/onc.2017.108] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 8.8] [Reference Citation Analysis]
107 Li Q, Xia S, Fang H, Pan J, Jia Y, Deng G. VEGF treatment promotes bone marrow-derived CXCR4+ mesenchymal stromal stem cell differentiation into vessel endothelial cells. Exp Ther Med 2017;13:449-54. [PMID: 28352314 DOI: 10.3892/etm.2017.4019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
108 Yumimoto K, Nakayama KI. Fbxw7 suppresses cancer metastasis by inhibiting niche formation. Oncoimmunology 2015;4:e1022308. [PMID: 26405580 DOI: 10.1080/2162402X.2015.1022308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
109 Low HB, Png CW, Li C, Wang Y, Wong SB, Zhang Y. Monocyte-derived factors including PLA2G7 induced by macrophage-nasopharyngeal carcinoma cell interaction promote tumor cell invasiveness. Oncotarget. 2016;7:55473-55490. [PMID: 27487154 DOI: 10.18632/oncotarget.10980] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
110 Wang T, Du M, Ji Z, Ding C, Wang C, Men Y, Liu S, Liang T, Liu X, Kang Q. Recombinant protein rMBP-NAP restricts tumor progression by triggering antitumor immunity in mouse metastatic lung cancer. Can J Physiol Pharmacol 2018;96:113-9. [PMID: 28863272 DOI: 10.1139/cjpp-2017-0186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
111 Hu Z, Brooks SA, Dormoy V, Hsu CW, Hsu HY, Lin LT, Massfelder T, Rathmell WK, Xia M, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Prudhomme KR, Colacci A, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Lowe L, Jensen L, Bisson WH, Kleinstreuer N. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis 2015;36 Suppl 1:S184-202. [PMID: 26106137 DOI: 10.1093/carcin/bgv036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
112 Han R, Gu S, Zhang Y, Luo A, Jing X, Zhao L, Zhao X, Zhang L. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling. Sci Rep 2018;8:9575. [PMID: 29934505 DOI: 10.1038/s41598-018-27810-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
113 Läubli H, Borsig L. Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis. Front Immunol 2019;10:2120. [PMID: 31552050 DOI: 10.3389/fimmu.2019.02120] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 14.7] [Reference Citation Analysis]
114 Zhao L, Wang Y, Xue Y, Lv W, Zhang Y, He S. Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion. Acta Biochim Biophys Sin 2015;47:890-8. [DOI: 10.1093/abbs/gmv095] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
115 Regis S, Caliendo F, Dondero A, Casu B, Romano F, Loiacono F, Moretta A, Bottino C, Castriconi R. TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells. Front Immunol 2017;8:868. [PMID: 28791023 DOI: 10.3389/fimmu.2017.00868] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
116 Rubinstein-Achiasaf L, Morein D, Ben-Yaakov H, Liubomirski Y, Meshel T, Elbaz E, Dorot O, Pichinuk E, Gershovits M, Weil M, Ben-Baruch A. Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells. Cancers (Basel) 2021;13:1472. [PMID: 33806906 DOI: 10.3390/cancers13061472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Kranjc MK, Novak M, Pestell RG, Lah TT. Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme. Radiol Oncol 2019;53:397-406. [PMID: 31747383 DOI: 10.2478/raon-2019-0057] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
118 Rivas-Fuentes S, Salgado-Aguayo A, Pertuz Belloso S, Gorocica Rosete P, Alvarado-Vásquez N, Aquino-Jarquin G. Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation. J Cancer 2015;6:938-52. [PMID: 26316890 DOI: 10.7150/jca.12286] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
119 Yu S, Huang S, Ding Y, Wang W, Wang A, Lu Y. Transient receptor potential ion-channel subfamily V member 4: a potential target for cancer treatment. Cell Death Dis 2019;10:497. [PMID: 31235786 DOI: 10.1038/s41419-019-1708-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
120 Liu GT, Huang YL, Tzeng HE, Tsai CH, Wang SW, Tang CH. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells. Cancer Lett 2015;357:476-87. [PMID: 25444917 DOI: 10.1016/j.canlet.2014.11.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
121 Derossi DR, Amarante MK, Guembarovski RL, de Oliveira CEC, Suzuki KM, Watanabe MAE, de Syllos Cólus IM. CCL5 protein level: influence on breast cancer staging and lymph nodes commitment. Mol Biol Rep 2019;46:6165-70. [PMID: 31691056 DOI: 10.1007/s11033-019-05051-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
122 Xu W, Zhao Q, Wu M, Fang M, Xu Y. MKL1 mediates TNF-α induced pro-inflammatory transcription by bridging the crosstalk between BRG1 and WDR5. J Biomed Res 2019;33:164-72. [PMID: 29109331 DOI: 10.7555/JBR.32.20170025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
123 Patil K, Kuttikrishnan S, Khan AQ, Ahmad F, Alam M, Buddenkotte J, Ahmad A, Steinhoff M, Uddin S. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways. Semin Cancer Biol 2021:S1044-579X(21)00296-0. [PMID: 34906723 DOI: 10.1016/j.semcancer.2021.12.003] [Reference Citation Analysis]
124 Jiang C, Starr S, Chen F, Wu J. Low-fidelity alternative DNA repair carcinogenesis theory may interpret many cancer features and anticancer strategies. Future Oncol 2016;12:1897-910. [PMID: 27166654 DOI: 10.2217/fon-2016-0066] [Reference Citation Analysis]
125 Mondadori C, Crippa M, Moretti M, Candrian C, Lopa S, Arrigoni C. Advanced Microfluidic Models of Cancer and Immune Cell Extravasation: A Systematic Review of the Literature. Front Bioeng Biotechnol 2020;8:907. [PMID: 32984267 DOI: 10.3389/fbioe.2020.00907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
126 Zhu S, Jiang L, Wang L, Wang L, Zhang C, Ma Y, Huang T. Identification of key genes and specific pathways potentially involved in androgen-independent, mitoxantrone-resistant prostate cancer. Cancer Manag Res 2019;11:419-30. [PMID: 30655694 DOI: 10.2147/CMAR.S179467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
127 Abboud D, Daubeuf F, Do QT, Utard V, Villa P, Haiech J, Bonnet D, Hibert M, Bernard P, Galzi JL, Frossard N. A strategy to discover decoy chemokine ligands with an anti-inflammatory activity. Sci Rep 2015;5:14746. [PMID: 26442456 DOI: 10.1038/srep14746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
128 Chiu TJ, Chen YJ, Kuo FY, Chen YY. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma. PLoS One 2020;15:e0240791. [PMID: 33306714 DOI: 10.1371/journal.pone.0240791] [Reference Citation Analysis]
129 Palange AL, Di Mascolo D, Carallo C, Gnasso A, Decuzzi P. Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells. Nanomedicine 2014;10:991-1002. [PMID: 24566270 DOI: 10.1016/j.nano.2014.02.004] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
130 el Aziz LM. Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4. Med Oncol. 2014;31:311. [PMID: 25367855 DOI: 10.1007/s12032-014-0311-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
131 Morein D, Erlichman N, Ben-Baruch A. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy. Front Immunol. 2020;11:952. [PMID: 32582148 DOI: 10.3389/fimmu.2020.00952] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
132 Pulliam SR, Pellom ST Jr, Shanker A, Adunyah SE. Butyrate regulates the expression of inflammatory and chemotactic cytokines in human acute leukemic cells during apoptosis. Cytokine 2016;84:74-87. [PMID: 27253488 DOI: 10.1016/j.cyto.2016.05.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
133 Roblek M, Strutzmann E, Zankl C, Adage T, Heikenwalder M, Atlic A, Weis R, Kungl A, Borsig L. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding. Neoplasia 2016;18:49-59. [PMID: 26806351 DOI: 10.1016/j.neo.2015.11.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]